302962-49-8 Dasatinib
Nome del prodotto |
Dasatinib |
Nome inglese |
Dasatinib; intermediate; N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide hydrate (1:1); BMS 354825; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide |
Formula molecolare |
C22H28ClN7O3S |
Peso Molecolare |
506.0208 |
InChI |
InChI=1/C22H26ClN7O2S.H2O/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31;/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27);1H2 |
Numero CAS |
302962-49-8 |
Struttura molecolare |
|
Simboli di pericolo |
|
Codici di Rischio |
|
Sicurezza Descrizione |
|
|